Theodora Temelkova‐Kurktschiev

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 3K citations · Full text

Medicine, Endocrinology, Pharmacology +14

Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 629 citations · Full text

Medicine, Endocrinology, Nephrology +15

Postchallenge plasma glucose and glycemic spikes are more strongly associated with atherosclerosis than fasting glucose or HbA1c level.

Theodora Temelkova‐Kurktschiev, Carsta Koehler, Elena Henkel et al. · Diabetes Care · 2000 · 548 citations · Full text

Medicine, Endocrinology, Clinical Nutrition +16

Effect of dulaglutide on cognitive impairment in type 2 diabetes: an exploratory analysis of the REWIND trial

Tali Cukierman‐Yaffe, Hertzel C. Gerstein, Helen M. Colhoun et al. · The Lancet Neurology · 2020 · 270 citations

Medicine, Pharmacology, Pharmacotherapy +14

Acarbose Slows Progression of Intima-Media Thickness of the Carotid Arteries in Subjects With Impaired Glucose Tolerance

M Hanefeld, Jean Louis Chiasson, Carsta Koehler et al. · Stroke · 2004 · 254 citations · Full text

Medicine, Endocrinology, Pharmacology +17